Publications

Filters

Publications Atlas Journal Article Research Report

Clinical and Practice Brain diseases Cancer and cancer screening Cardiovascular disease Chronic diseases and multimorbidity Diet and nutrition Endocrinology Environmental health Eye, ear, nose and throat disorders Gastroenterology Hematology Infectious diseases Injuries and accidents Internal medicine Kidney disease Lung health Musculoskeletal diseases and disorders Organ transplantation and donation Pharmacoepidemiology and drug safety Reproductive medicine Skin diseases and disorders

Healthcare Providers and Services Acute and emergency services End-of-life care Home and community care Long-term care and continuing care Maternity and neonatal care Mental health and addictions Nursing Pediatrics Pharmacy Primary care Public health Rehabilitation Surgery

People and Society Children and young people Health and healthcare inequality Indigenous Peoples Marginalized populations Older people Racialized communities Women or gender-based research

Research and Methods Data science Decision science Epidemiology Health economics Health services research Implementation science and knowledge translation Policy and program evaluation Statistics Trials

From

ICES Central ICES McMaster ICES North ICES Queen's ICES UofT ICES uOttawa ICES Western

Cancer Cardiovascular Chronic Disease & Pharmacotherapy Kidney, Dialysis & Transplantation Life Stage Mental Health & Addictions Populations & Public Health Primary Care & Health Systems

Showing 1-10 of 145

Journal Article

26/05/2020

Effect of academic detailing on promoting appropriate prescribing of antipsychotic medication in nursing homes: a cluster randomized clinical trial

Tadrous M, Fung K, Desveaux L, Gomes T, Taljaard M, Grimshaw JM, Bell CM, Ivers NM. JAMA Netw Open. 2020; 3(5):e205724. Epub 2020 May 26.

Journal Article

14/05/2020

Identifying drugs with disease‐modifying potential in Parkinson’s disease using artificial intelligence and pharmacoepidemiology

Maclagan LC, Visanji NP, Cheng Y, Tadrous M, Lacoste AMB, Kalia LV, Bronskill SE, Marras C. Pharmacoepidemiol Drug Saf. 2020; 29(8):864-72. Epub 2020 May 14.

Journal Article

28/04/2020

Characteristics of high–drug-cost beneficiaries of public drug plans in 9 Canadian provinces: a cross-sectional analysis

Tadrous M, Martins D, Mamdani MM, Gomes T. CMAJ Open. 2020; 8(2):E297-303. Epub 2020 Apr 28.

Journal Article

10/01/2020

Impact of a publicly funded herpes zoster immunization program on the burden of disease in Ontario, Canada: a population-based study

Martins D, McCormack D, Tadrous M, Gomes T, Kwong JC, Mamdani MM, Buchan SA, Antoniou T. Clin Infect Dis. 2021; 72(2):279-84. Epub 2020 Jan 10.

Journal Article

05/12/2019

Assessing the impact of an opioid prescribing guideline for dentists in Ontario, Canada

Guan Q, Campbell T, Martins D, Tadrous M, Juurlink D, Paterson M, Mamadani M, Mock D, Gomes T. J Am Dent Assoc. 2020; 151(1):43-50. Epub 2019 Dec 5.

Journal Article

23/09/2019

Time trends in opioid prescribing among Ontario long-term care residents: a repeated cross-sectional study

Iaboni A, Campitelli MA, Bronskill SE, Diong C, Kumar M, Maclagan LC, Gomes T, Tadrous M, Maxwell CJ. CMAJ Open. 2019; 7(3):E582-9. Epub 2019 Sep 23.

Journal Article

31/07/2019

Antipsychotic initiation among adults with intellectual and developmental disabilities in Ontario: a population-based cohort study

Gomes T, Khuu W, Tadrous M, Vigod S, Cobigo V, Lunsky Y. BMJ Open. 2019; 9:e028125. Epub 2019 Jul 31.

Journal Article

15/07/2019

Association of mirabegron with the risk of arrhythmia in adult patients 66 years or older—a population-based cohort study

Tadrous M, Matta R, Greaves S, Herschorn S, Mamdani MM, Juurlink DN, Gomes T. JAMA Intern Med. 2019; 179(10):1436-9. Epub 2019 Jul 15.

Journal Article

01/05/2019

Quality of primary care among individuals receiving treatment for opioid use disorder

Spithoff S, Kiran T, Khuu W, Kahan M, Guan Q, Tadrous M, Leece P, Martins D, Gomes T. Can Fam Physician. 2019; 65(5):343-51. Epub 2019 May 1.

Journal Article

14/03/2019

Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada

Martins D, Khuu W, Tadrous M, Juurlink DN, Mamdani MM, Paterson JM, Gomes T. Pharmacoepidemiol Drug Saf. 2019; 28(5):726-33. Epub 2019 Mar 14.

« Previous 1 … 9 10 11 12 13 … 15 Next »

Publications

Filters

Resource Type

Topic

Date

ICES Scientists

ICES Site

Research Program

Effect of academic detailing on promoting appropriate prescribing of antipsychotic medication in nursing homes: a cluster randomized clinical trial

Identifying drugs with disease‐modifying potential in Parkinson’s disease using artificial intelligence and pharmacoepidemiology

Characteristics of high–drug-cost beneficiaries of public drug plans in 9 Canadian provinces: a cross-sectional analysis

Impact of a publicly funded herpes zoster immunization program on the burden of disease in Ontario, Canada: a population-based study

Assessing the impact of an opioid prescribing guideline for dentists in Ontario, Canada

Time trends in opioid prescribing among Ontario long-term care residents: a repeated cross-sectional study

Antipsychotic initiation among adults with intellectual and developmental disabilities in Ontario: a population-based cohort study

Association of mirabegron with the risk of arrhythmia in adult patients 66 years or older—a population-based cohort study

Quality of primary care among individuals receiving treatment for opioid use disorder

Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada